Clinical trial
Irbesartan in Hypertension
NCT00265967 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00265967 |
|---|---|
| Title | Irbesartan in Hypertension |
| Official title | Missed Dose Effect of Irbesartan in Hypertensive Patients and Cardiovascular Risk Profile Monitoring Under Irbesartan Treatment |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan |
| Enrollment | 88 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2007 |
| First posted | Dec 15, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: